COMMUNIQUÉS West-GlobeNewswire

Immuneering Reports Third Quarter 2026 Financial Results and Provides Business Updates
29/10/2026
- Phase 2 pancreatic cancer follow-up extended as patients on atebimetinib combinations live longer than projected - - Updated Phase 2 atebimetinib + mGnP pancreatic cancer data (N=55) expected in the first half of 2027 [...]
FOXO TECHNOLOGIES INC. ANNOUNCES AGREEMENTS TO ACQUIRE PREFERRED STOCK CARRYING MAJORITY VOTING POWER IN LUDWIG ENTERPRISES, INC.
29/10/2026
WEST PALM BEACH, FL, Oct. 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc . (OTC: FOXO) (“FOXO” or the “Company”) today announced that it has entered into Stock Purchase Agreements to acquire shares of preferred [...]
Stryker reports third quarter 2026 operating results
29/10/2026
Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026: Third Quarter Results Reported net sales increased 7.7% to $6.5 billion Organic net sales [...]
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
29/10/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
29/10/2026
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91 Returned more than $1.0 billion to [...]
Supernus Announces Third Quarter 2026 Financial Results
29/10/2026
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $192.2 million in the third [...]
Strom Strategies Calls for a Possible "Black Box Warning" on Al Sayed’s Medicare for All Proposal
29/10/2026
Dr. Joel Strom raises questions about expanding the ACA, patient choice and the need for clear evidence on the plan’s effects. Frisco, TX, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Strom Strategies today called for a detailed [...]
Trethera Selected as a 2026–2027 National Cancer Institute Investor Showcase Company
29/10/2026
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Retinal Robotics Pioneers Launch VisioSurgical Solutions (VSS) to Bring Compact Surgical Robots to Every Retina Surgeon
29/10/2026
LAUSANNE, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- VisioSurgical Solutions (VSS) , a Swiss medical robotics company founded by the team behind the first retinal surgery robot, today announced its launch and the [...]
Life with Jan Collaborates with Perrine SDA Church to Bring Renowned Physician Dr. Neil Nedley to South Florida
29/10/2026
Free November 6–7 Community Wellness Seminar Explores Depression, Anxiety, Brain Health, and Cancer Through a Wholistic Approach to Health and Wellbeing Miami, FLORIDA, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Life with Jan, [...]
Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
29/10/2026
Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdings TA-125 tracks the 125 largest and most prominent companies on the TASE JERUSALEM, Oct. 29, 2026 (GLOBE NEWSWIRE) -- [...]
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
29/10/2026
Peer-reviewed publication reinforces efzofitimod’s differentiated profile and potential to advance pulmonary sarcoidosis care. SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the [...]
MediWound to Report Third Quarter 2026 Financial Results
29/10/2026
MediWound to Report Third Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, November 12 th at 8:30 a.m. Eastern Time YAVNE, Israel, October 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a [...]
SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference
29/10/2026
JERSEY CITY, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases, today announced that the [...]
Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men’s Hockey Championship
29/10/2026
$100 from every bottle sold will benefit Denver men’s ice hockey scholarships DENVER, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery , an award-winning craft distillery and subsidiary of Tilray Brands, Inc. ( [...]
Immutep Quarterly Activities Report Q1 FY27
29/10/2026
Media Release Immutep intends to focus the registration-directed clinical development of efti on HNSCC in patients with CPS <1 and the neoadjuvant setting of STS, with preparations for future clinical trials underway [...]
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
29/10/2026
Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company [...]
Oak Hill Bio to Present at Upcoming Investor Conferences
29/10/2026
CAMBRIDGE, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced that the company will participate in the following investor [...]
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
29/10/2026
U.S. FDA clears IND for Phase 2 study of VT-7208 in chronic spontaneous urticaria; additional Phase 2 studies planned in food allergy and relapsing multiple sclerosis Company expands pipeline through research [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum